Last reviewed · How we verify
Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
The purpose of this study is to find if Etanercept can improve the outcome of ocular lesions of Behcet's Disease treated with Methotrexate and Prednisolone
Details
| Lead sponsor | Tehran University of Medical Sciences |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 80 |
| Start date | 2010-10 |
| Completion | 2013-10 |
Conditions
- Behcet Syndrome
- Uveal Disease
Interventions
- Etanercept, Methotrexate, Prednisolone
Primary outcomes
- Visual Acuity, Disease Activity Index (DAI) for Posterior Uveitis, DAI for Retinal vasculitis — One Year
Countries
Iran